S&P 500   3,988.66 (+0.94%)
DOW   32,438.95 (+0.60%)
QQQ   308.42 (+0.80%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,988.66 (+0.94%)
DOW   32,438.95 (+0.60%)
QQQ   308.42 (+0.80%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,988.66 (+0.94%)
DOW   32,438.95 (+0.60%)
QQQ   308.42 (+0.80%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
S&P 500   3,988.66 (+0.94%)
DOW   32,438.95 (+0.60%)
QQQ   308.42 (+0.80%)
AAPL   158.58 (+0.75%)
MSFT   272.72 (+0.18%)
META   200.08 (+1.15%)
GOOGL   104.55 (+3.29%)
AMZN   99.52 (+1.85%)
TSLA   196.10 (+7.01%)
NVDA   259.30 (+0.12%)
NIO   9.23 (+5.49%)
BABA   83.37 (+2.93%)
AMD   95.11 (-1.76%)
T   18.46 (-0.16%)
F   11.75 (+5.10%)
MU   58.26 (+1.08%)
CGC   1.98 (+6.45%)
GE   92.54 (+2.91%)
DIS   96.25 (+2.15%)
AMC   4.40 (+3.04%)
PFE   40.42 (-0.96%)
PYPL   75.84 (+3.59%)
NFLX   305.24 (+0.04%)
OTCMKTS:BFNH

BioForce Nanosciences - BFNH Stock Forecast, Price & News

$1.75
-0.70 (-28.57%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.19
▼
$2.48
50-Day Range
$2.07
▼
$2.88
52-Week Range
$0.89
▼
$3.47
Volume
33,054 shs
Average Volume
438 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BFNH stock logo

About BioForce Nanosciences (OTCMKTS:BFNH) Stock

BioForce Nanosciences Holdings, Inc. provides natural vitamins, minerals, nutritional supplements, powders and beverages. It markets products through social media and telemarketing. The company was founded on December 10, 1999 and is headquartered in Virginia Beach, VA.

Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

BFNH Stock News Headlines

August 20, 2022 | ca.finance.yahoo.com
BioForce Nanosciences Holdings, Inc. (BFNH)
January 23, 2022 | nasdaq.com
BioForce Nanosciences Holdings Inc (BFNH)
March 21, 2023 | PressReach (Ad)
This Stock Has Room To Run
Analysts believe this stock's product demand could rise quickly in the next few years.
August 25, 2021 | barrons.com
BioForce Nanosciences Holdings Inc.
August 11, 2021 | finance.yahoo.com
Element Global, Inc. (ELGL) Announces Signing MOU With Bioforce Nanosciences Holdings, Inc. (BFNH)
See More Headlines
Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

BFNH Company Calendar

Today
3/21/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BFNH
CUSIP
N/A
CIK
1310488
Web
www.bioforceeclipse.com
Phone
(757) 306-6090
Fax
757-306-6092
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-500,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-6,104.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.06) per share
Price / Book
-29.17

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-1.48

Key Executives

  • Steven F. Gagnon
    Co-Chief Executive Officer
  • John S. LaViolette
    Co-Chief Executive Officer
  • Sasha Shapiro
    President
  • Richard James Kaiser
    Chief Financial Officer, Secretary & Director

Key Competitors

View All Competitors













BFNH Stock - Frequently Asked Questions

How have BFNH shares performed in 2023?

BioForce Nanosciences' stock was trading at $1.99 at the beginning of 2023. Since then, BFNH shares have decreased by 12.1% and is now trading at $1.75.
View the best growth stocks for 2023 here.

What is BioForce Nanosciences' stock symbol?

BioForce Nanosciences trades on the OTCMKTS under the ticker symbol "BFNH."

How do I buy shares of BioForce Nanosciences?

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioForce Nanosciences' stock price today?

One share of BFNH stock can currently be purchased for approximately $1.75.

How can I contact BioForce Nanosciences?

BioForce Nanosciences' mailing address is 2020 GENERAL BOOTH BLVD UNIT 230, VIRGINIA BEACH VA, 23454. The official website for the company is www.bioforceeclipse.com. The company can be reached via phone at (757) 306-6090, via email at info@bioforcenano.com, or via fax at 757-306-6092.

This page (OTCMKTS:BFNH) was last updated on 3/21/2023 by MarketBeat.com Staff